B. Dorsey

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials

J. Mascola, T. Pierson, C. Andrews, 2017, The Lancet.

Docetaxel followed by hormone therapy in men experiencing increasing prostate-specific antigen after primary local treatments for prostate cancer.

A. Hussain, N. Dawson, B. Dorsey, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Trial of Gefitinib (Iressa, ZD1839) in Stage IV and Recurrent Renal Cell Carcinoma

A. Hussain, N. Dawson, B. Dorsey, 2004, Clinical Cancer Research.

A Phase II Trial of Gefitinib ( Iressa , ZD 1839 ) in Stage IV and Recurrent Renal Cell Carcinoma

A. Hussain, N. Dawson, B. Dorsey, 2004 .

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial.

Zonghui Hu, A. McDermott, J. Gall, 2023, The Lancet. Infectious diseases.